Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Tesamorelins FDA approval in 2010 was specifically for HIV-associated lipodystrophy, following pivotal trials published in The Lancet that demonstrated an approximately 15% reduction in visceral adipose tissue over 26 weeks
Fan G et al
Avoid administration immediately after meals, particularly high-carbohydrate meals
Persistent or severe symptoms suggest dose reduction or potential sensitivity
Our licensed professionals design each injection to optimize energy, mental clarity, and overall wellness, taking into account lifestyle, dietary habits, and health goals for maximum results
US$ 21.30
US$ 21.59
US$ 20.25
US$ 20.55
